Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era.
Antibiotic resistance profiles are useful in directing therapeutic strategies during bacterial infections. Patterns of antimicrobial resistance in Streptococcus pneumoniae and Pseudomonas aeruginosa associated pneumonia were investigated in an HIV-1 infected cohort during the era of highly active antiretroviral therapy. The median CD4 count at presentation was significantly lower for cases of P aeruginosa than for S pneumoniae. However, the number of antibiotic resistant cases of P aeruginosa decreased throughout the study period, while the incidence of S pneumoniae remained unchanged. In contrast to pneumococcal pneumonia, we show that antiretrovirals have protected from pneumonia due to antibiotic resistant P aeruginosa. These findings have implications for the treatment of individuals presenting with serious infections in which antibiotic therapy needs to be instituted before identification and sensitivities are known.
Allen
S H
SH
Department of Microbiology, Chelsea and Westminster Hospital, London.
Brennan-Benson
P
P
Nelson
M
M
Asboe
D
D
Bower
M
M
Azadian
B
B
Gazzard
B
B
Stebbing
J
J
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D015331:Cohort Studies; D024881:Drug Resistance, Bacterial; D005260:Female; D015497:HIV-1; D006801:Humans; D008297:Male; D018410:Pneumonia, Bacterial / Q000150:complications / Q000188:drug therapy*; D011018:Pneumonia, Pneumococcal / Q000150:complications / Q000188:drug therapy; D019562:Viral Load
D000890:Anti-Infective Agents